← Eric N. Olson

Papers by Eric N. Olson

Page 1 · newest first

1. Annexins cooperate with Myomaker to promote myoblast fusionProceedings of the National Academy of Sciences · 2026
2. Histone lysine demethylase inhibition is a disease-modifying therapy for hypertrophic cardiomyopathy2026
3. A developmentally restricted γδ T cell-IL-17A axis supports mouse heart regenerationCell Reports · 2026
4. Genetic and regenerative contexts specify distinct soft tissue sarcoma identities from Twist2+ progenitorsProceedings of the National Academy of Sciences · 2026
5. Myogenic Fusogen‐Engineered Lipid Nanoparticles Enhance mRNA Delivery in Skeletal MuscleAdvanced Functional Materials · 2026
6. MicroRNAs Add a New Dimension to Cardiovascular DiseaseCirculation · 2010
7. Precision modification of heart failure signaling by CRISPR-Cas9 base editingJournal of Molecular and Cellular Cardiology · 2026
8. A human cardiomyocyte screen identifies optimized lipid nanoparticles for in vivo cardiac gene editingProceedings of the National Academy of Sciences · 2026
9. Nrf1 coordinates proteasome activity and autophagy to maintain cardiac proteostasisCommunications Biology · 2026
10. Abstract 3366: Muscle iron overload contributes to cancer cachexia-induced muscle wastingCancer Research · 2026
11. Infrared Thermal Imaging Enhanced Selection Intensity for Fusarium Head Blight Resistance in Soft Winter WheatPlant Breeding · 2025
12. Modulation of the JAK2-STAT3 pathway promotes expansion and maturation of human iPSC-derived myogenic progenitor cellsStem Cell Reports · 2025
13. Precise gene editing of pathogenic Lamin A mutations corrects cardiac diseaseProceedings of the National Academy of Sciences · 2025
14. Engineering a serum response factor superactivator of smooth muscle gene expression with a condensate-forming domainProceedings of the National Academy of Sciences · 2025
15. Gene Editing Applications as Future Cardiovascular TherapiesAnnual Review of Genetics · 2025
16. Cellular Reprogramming by PHF7 Enhances Cardiac Function Following Myocardial InfarctionCirculation · 2025
17. A mechanistic basis of fast myofiber vulnerability to neuromuscular diseasesSHILAP Revista de lepidopterología · 2025
18. Genomic Editing of a Pathogenic Sequence Variant in ACTA2 Rescues Multisystemic Smooth Muscle Dysfunction Syndrome in MiceCirculation · 2025
19. Optimized genomic editing of a common Duchenne muscular dystrophy mutation in patient-derived muscle cells and a new humanized mouse modelMolecular Therapy — Nucleic Acids · 2025
20. SARS-CoV-2 humoral immune responses in convalescent individuals over 12 months reveal severity-dependent antibody dynamicsCommunications Medicine · 2025
21. Comparative Analysis of LLM-Generated Event Timeline Summarization for Legal Investigations2024
22. Modulation of the JAK2-STAT3 pathway promotes expansion and maturation of human iPSCs-derived myogenic progenitor cells2024
23. A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolutionCell Reports · 2024
24. Myocardial Regeneration: Feasible or Fantasy?Circulation · 2024
25. Abstract 1097: CD73 contributes to the pathogenesis of fusion-negative rhabdomyosarcoma through the purinergic signaling pathwayCancer Research · 2024
26. Coactivator condensation drives cardiovascular cell lineage specificationScience Advances · 2024
27. CD73 contributes to the pathogenesis of fusion-negative rhabdomyosarcoma through the purinergic signaling pathwayProceedings of the National Academy of Sciences · 2024
28. SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody Dynamics2023
29. DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum ClustersCirculation Research · 2023
30. RBPMS regulates cardiomyocyte contraction and cardiac function through RNA alternative splicingCardiovascular Research · 2023
31. CRISPR-Cas9 base editing of pathogenic CaMKIIδ improves cardiac function in a humanized mouse modelJournal of Clinical Investigation · 2023
32. Elimination of CaMKIIδ Autophosphorylation by CRISPR-Cas9 Base Editing Improves Survival and Cardiac Function in Heart Failure in MiceCirculation · 2023
33. Opposing gene regulatory programs governing myofiber development and maturation revealed at single nucleus resolutionNature Communications · 2023
34. Net39 protects muscle nuclei from mechanical stress during the pathogenesis of Emery-Dreifuss muscular dystrophyJournal of Clinical Investigation · 2023
35. TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcomaScience Advances · 2023
36. Single-swap editing for the correction of common Duchenne muscular dystrophy mutationsMolecular Therapy — Nucleic Acids · 2023
37. CRISPR-Editing Therapy for Duchenne Muscular DystrophyHuman Gene Therapy · 2023
38. Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapiesInternational Immunopharmacology · 2023
39. Ablation of CaMKIIδ oxidation by CRISPR-Cas9 base editing as a therapy for cardiac diseaseScience · 2023
40. Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathyScience Translational Medicine · 2022
41. Loss of function of the nuclear envelope protein LEMD2 causes DNA damage–dependent cardiomyopathyJournal of Clinical Investigation · 2022
42. Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophyJournal of Cachexia Sarcopenia and Muscle · 2022
43. Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapyMultiple Sclerosis and Related Disorders · 2022
44. A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editingMolecular Therapy — Nucleic Acids · 2022
45. CRISPR Modeling and Correction of Cardiovascular DiseaseCirculation Research · 2022
46. Impaired activity of the fusogenic micropeptide Myomixer causes myopathy resembling Carey-Fineman-Ziter syndromeJournal of Clinical Investigation · 2022
47. Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD miceMolecular Therapy — Nucleic Acids · 2022
48. The cardiac-enriched microprotein mitolamban regulates mitochondrial respiratory complex assembly and function in miceProceedings of the National Academy of Sciences · 2022
49. Defining cellular complexity in human autosomal dominant polycystic kidney disease by multimodal single cell analysis2021
50. Nrf1 promotes heart regeneration and repair by regulating proteostasis and redox balanceNature Communications · 2021